Experience
Duchesnay
Actavis Laboratories Inc.; Mylan Pharmaceuticals, Inc.
Represented Duchesnay in Hatch-Waxman litigation, defending against generic attack on Duchesnay's Diclegis® product.
Duchesnay v. Actavis Laboratories Inc.; Mylan Pharmaceuticals, Inc., 1:14-cv-00912, D. Del., Judges Robinson, Fallon
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
Duchesnay Inc.
Abbott Laboratories v. Sandoz Inc.
Abbott Laboratories
AbbVie Inc. v. Roxane Laboratories Inc.
AbbVie Inc.
Eli Lilly and Company v. Actavis Labs. UT Inc.
Eli Lilly and Company
AstraZeneca AB v. Lannett Holdings, Inc.
AstraZeneca AB
Richardson-Vicks Inc. v. American Home Products
American Home Products
Finnegan secures 10 years of patent protection for Relistor®
Valeant; Salix; Progenics
AbbVie Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.